%0 Journal Article %T Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial %A Pan, Lanlan %A Tian, Yitong %A Wang, Kangxin %A Tang, Jie %A Liu, Jin %A Zhang, Jiaguang %A Wang, Min %A Liu, Jie %A Xu, Hao %A Chen, Xiaofeng %J Journal of Gastrointestinal Oncology %D 2022 %B 2022 %9 %! Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial %K %X %U https://jgo.amegroups.org/article/view/71066 %V 13 %N 6 %P 3300-3313 %@ 2219-679X